...
首页> 外文期刊>Annales de biologie clinique >Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives
【24h】

Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives

机译:粪钙卫蛋白剂量对炎症性肠病的兴趣,最新技术和观点

获取原文
获取原文并翻译 | 示例
           

摘要

Inflammatory bowel diseases are chronic diseases that result from an inflammation of the intestinal wall. They are suspected in any patient presenting with intestinal symptoms. Until recently, diagnosis was mainly based both on clinical and endoscopic arguments. The use of an easy, fast, reliable, non-invasive and inexpensive test must not only assist in the diagnosis but also contribute to their evolutionary and therapeutic monitoring. To date, fecal calprotectin is the most documented in this perspective. This marker allows to discriminate between functional and organic bowel processes with good sensitivity and good specificity. The determination of the fecal calprotectin level in stools contributes to the evaluation of the degree of disease activity and monitoring of therapeutic response.
机译:肠炎是由肠壁发炎引起的慢性疾病。在任何出现肠道症状的患者中都怀疑它们。直到最近,诊断主要基于临床和内窥镜检查。使用简单,快速,可靠,无创且便宜的测试不仅必须有助于诊断,而且还必须对其进化和治疗进行监测。迄今为止,从这个角度来看,粪便钙卫蛋白的文献最多。该标记物可以高灵敏度和高特异性区分功能性肠和有机性肠过程。粪便中钙卫蛋白水平的测定有助于疾病活动度的评估和治疗反应的监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号